Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.

Similar documents
BREATHLESSNESS MANAGEMENT

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.

End Stage Liver Disease Regional Audit Casenote Survey

Palliative Emergencies. Ken Stakiw

Breathlessness in advanced disease. February 2017

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

Palliative Care Emergencies. Additional module if needed

Renal Palliative Care Last Days of Life

Dyspnea. Stephanie Lindsay

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

Palliative care for heart failure patients. Susan Addie

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

Supportive Care. End of Life Phase

Syringe driver in Palliative Care

This survey aims to look at individual practice and can be completed by any healthcare professional.

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

Palliative Care Impact Survey

Non Pharmacological Breathlessness and Fatigue Management

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

STEROID GUIDELINES AUDIT RESULTS

5/3/2012 PRESENTATION GOALS RESPIRATORY THERAPISTS ROLE IN END OF LIFE CARE FOR THE PULMONARY PATIENT

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

Care in the Last Days of Life

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

2018 OCN Keywords January 22, 2018 Subject Area Weight Keywords

Dyspnea: The top things you need to you know! Dr. Megan Sellick & Dr. Lawrence Lee Edmonton Zone Palliative Care Program

Symptom Management and Palliative Care for Lung Cancer

Renal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life

APHN. Shortness of breath. Ednin Hamzah CEO, Hospis Malaysia.

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

MND Just in Case kit Information for GPs

Dr. A. Kerigan BREATHLESSNESS AT THE END OF LIFE

Bronchodilator Delivery and Nebuliser Trials in Adults

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

PRACTICAL DYSPNEA MANAGEMENT Margot Sondermann BScPT, MEd. Palliative Consultant for End-Stage Lung Disease, Calgary Zone

Care of the Dying Management in Severe Renal Failure

Conservative Management of Uraemia

Dyspnea: Evaluation and Management

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

Palliative care for patients with brain cancer

Tracy Ward Highly Specialist Respiratory Nurse Rotherham NHS Foundation Trust

Screening - inclusion criteria

Primary Diagnosis YES NO ICD - Code Cancer Cognitive impairment Cardiac Respiratory Neurological Musculoskeletal Respiratory Other

Management of Dyspnea and Cough in Lung Cancer

Regional Renal Training

describe the epidemiological and clinical features along the illness trajectories of specific lifelimiting

Course Handouts & Disclosure

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

Screening - inclusion criteria

Palliative Care Emergencies

Sam H Ahmedzai Academic Unit of Supportive Care Department of Oncology The University of Sheffield & Sheffield Teaching Hospitals NHS Foundation

Respiratory Issues at End-of-Life. Jerry Boltz, FNP January 27, L N E C Geriatric Curriculum

Symptom Control in Heart Failure. Dr Claire L Hookey

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

Care of the Dying Management in Severe Renal Failure

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

information Chronic Obstructive Pulmonary Disease - COPD (1 of 5) What is COPD? What is going on in my lungs? What are the symptoms of COPD?

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

I have no financial disclosures.

JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES

8. Pharmacological Management

Self-management plan for COPD

Algorithms for Symptom Management. In End of Life Care

AND CHEMOTHERAPY IN PALLIATIVE CARE

COPD AND PALLIATIVE CARE JEAN WATERS FNP-BC SENTARA RMH PALLIATIVE CARE JANUARY 13, 2018

Gestione della dispnea nell insufficienza respiratoria end-stage

Approach to symptom control near the end-of-life

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

A NEBULISERS AND NEBULISED MEDICATION. Generic Guide for the use of nebulisers and nebulised medication

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

OPAT FOR INFECTION IN BRONCHIECTASIS

BTS Guideline for Home Oxygen use in adults Appendix 9 (online only) Key Questions - PICO 10 December 2012

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

Managing Exacerbations of COPD (Version 3.0)

BACKGROUND Measuring renal function :

Chronic obstructive pulmonary disease

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

Supported by an educational grant from

In our patients the cause of seizures can be broadly divided into structural and systemic causes.

The last days of life in hospital and at home

GUIDELINES & PROTOCOLS

Pulmonary Rehabilitation Information Leaflet

What s New 2003? What new treatments? What have you discontinued? More information please!

Nausea and Vomiting. Principles and Practice in End of Life Care November 2018

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

Palliative care Non-malignant Respiratory Disease. Scott Davidson Queen Elizabeth University Hospital Glasgow

INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT

Patient Profile. Patient s details Initials: IF Age: 40 Gender: Male. Weight: 139.7kg Height: 510 metres BMI: >47

Patient demographics Patient name Date of birth Gender NHS number SMITH, Robert (Mr) 01-Feb-1950 Male Verified

NEBULISERS AND NEBULISED MEDICATION. A Guide for the use of nebulisers and nebulised medication in the community setting

Transcription:

Regional Breathlessness Audit - Case te Survey 1. Introduction Please complete this form for your case note review. Cases used may be PROSPECTIVE AND/OR RETROSPECTIVE. Please log as many cases as you can. If you have any questions about how this form should be completed please contact Joanna.roberts5@nhs.net Regional Breathlessness Audit - Case te Survey 2. Demographics Please complete the patient's demographic details. If you have any questions about how this form should be completed please contact YOUR EMAIL ADDRESS. * 1. Patient s Specialist Palliative Care Service Group (SPCSG) * 2. Patient s SPCSG Location & Service * 3. Age * 4. Sex: Female Male * 5. Patient s Place of Care Home Nursing Home Hospice Hospital Regional Breathlessness Audit - Case te Survey 3. Initial Assessment by Palliative Care Professional 1

1. What is the diagnosis? Cancer (lung primary) Cancer (not lung primary) Heart failure COPD Pulmonary fibrosis Renal failure Hepatic failure Neurological condition 2. Was a reversible cause for breathlessness identified and documented? 3. If yes, was this treated? reversible cause documented t possible or appropriate to treat 4. On initial assessment was there documentation of: A chest examination Fluid volume status Oxygen saturations at rest Oxygen saturations post exertion Full blood count Chest X-ray 5. On initial assessment was there evidence of documentation of: Exercise tolerance Functional ability e.g. ADLs Associated panic 6. Has the cause of breathlessness been clearly documented? Regional Breathlessness Audit - Case te Survey 4. n Pharmacological Management 2

1. n Pharmacological management. Was there documentation of use of: Handheld fan Pacing/energy conservation Breathing techniques Relaxation Exercise Complimentary therapies Education Positioning 2. Was there documentation that the patient was referred to? Physiotherapy Occupational therapy Complimentary therapies t appropriate for therapy referral (please expand) Regional Breathlessness Audit - Case te Survey 5. Benzodiazepines 1. Was it documented the patient had anxiety or panic? 2. If yes, was the patient commenced on anxiolytics (e.g. a benzodiazepine) 3. How is it prescribed? Regular use PRN basis Both Benzodiazepine not prescribed 3

4. If a benzodiazepine was used, which one? Lorazepam Diazepam Temazepam Clonazepam Other (please state) Benzodiazepine not prescribed Regional Breathlessness Audit - Case te Survey 6. Opioids 1. On initial assessment was the patient already prescribed an opioid for breathlessness? 2. If no, on initial assessment was an opioid commenced for breathlessness? Already prescribed opioid for breathlessness 3. If opioid prescribed, what opioid was commenced for breathlessness management? Morphine (instant release) Morphine (modified release) Morphine (via syringe driver) Oxycodone (instant release) Oxycodone (modified release) Oxycodone (via syringe driver) Diamorphine (via syringe driver) Alfentanil (via syringe driver) Hydromorphone Other (please state) Regional Breathlessness Audit - Case te Survey 7. Nebulised Medication 4

1. Have nebulised medication been used in the management of breathlessness in this patient? 2. If yes, which nebulised medications? (please tick all that apply) Saline Salbutamol Ipatropium bromide Nebulised opioids Nebulised antibiotics Nebulised medication not prescribed Other 3. Was any adverse reaction to nebulised medication recorded? Regional Breathlessness Audit - Case te Survey 8. Steroids 1. Was the patient commenced on steroids during the care episode? 2. If yes, was the indication for steroids documented? Fatigue Appetite stimulant Pain Superior vena cava obstruction Metastatic spinal cord compression Cerebral oedema Lymphangitis Nausea Bowel obstruction Indication not documented Other 5

Regional Breathlessness Audit - Case te Survey 9. Other Treatment 1. During the care episode was the patient having any other concurrent treatment for the management of breathlessness? Antibiotics Radiotherapy Low molecular weight heparin Diuretics Blood transfusion Inhalers Oxygen Other Regional Breathlessness Audit - Case te Survey 10. Thank You Thank you for completing the survey. If you wish to submit more examples click on the Done button and enter this address again: ENTER SURVEY WEB ADDRESS HERE 6